as on October 23, 2025 at 8:42 pm IST
Day's Low
Day's High
3.32%
Downside
-0.41%
Upside
52 Week's Low
52 Week's High
42.32%
Downside
56.43%
Upside
Check Whitehawk Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$87.2M
EPS (TTM)
-0.74
Dividend Yield
0.00%
PE Ratio (TTM)
12.33
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
17.69%
Track how Whitehawk Therapeutics Inc P/E has moved over time to understand its valuation trends.
Whitehawk Therapeutics Inc in the last 5 years
Lowest (-1.00x)
March 31, 2025
Industry (0.00x)
October 23, 2025
Today (12.33x)
October 23, 2025
Highest (-0.80x)
June 30, 2025
Today’s Price to Earnings Ratio: 12.33x
Compare market cap, revenue, PE, and other key metrics of Whitehawk Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $87.2M | NA | 12.33 | 99.42% | |
BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
NA | $35.3B | NA | NA | -3.89% | |
BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
BUY | $61.3B | 0.85% | 14.6 | 31.37% |
Search interest for Whitehawk Therapeutics Inc Stock has increased by 975% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:975% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, WHWK stock has moved up by 23.4%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.7% return, outperforming this stock by 34.9%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.8% return, outperforming this stock by 215.3%
Revenue Fall
Revenue is down for the last 2 quarters, 7.23M → 7.14M (in $), with an average decrease of 1.3% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 73.01M → -52.61M (in $), with an average decrease of 172.1% per quarter
Organisation | Whitehawk Therapeutics Inc |
Headquarters | 2 Headquarters Plaza, Morristown, NJ, United States, 07960 |
CEO | Dr. David J. Lennon Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Bryan Ball | Chief Technical Operations Officer |
Dr. David Dornan Ph.D. | Chief Scientific Officer |
Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel |
Dr. David J. Lennon Ph.D. | President, CEO & Director |
Dr. Neil P. Desai Ph.D. | Founder & Director |
Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications |
Whitehawk Therapeutics Inc share price today is $2.41 as on . Whitehawk Therapeutics Inc share today touched a day high of $2.4 and a low of $2.33.
Whitehawk Therapeutics Inc share touched a 52 week high of $3.77 on and a 52 week low of $1.39 on . Whitehawk Therapeutics Inc stock price today i.e. is trending at $2.41,which is 36.07% down from its 52 week high and 73.38% up from its 52 week low.
Whitehawk Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Whitehawk Therapeutics Inc (WHWK) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Whitehawk Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Whitehawk Therapeutics Inc share’s latest price of $2.41 as on October 23, 2025 at 8:42 pm IST, you will get 4.1494 shares of Whitehawk Therapeutics Inc. Learn more about
fractional shares .